Atara Biotherapeutics Inc logo

ATRA - Atara Biotherapeutics Inc News Story

$13.91 0.7  5.1%

Last Trade - 11/05/21

Mid Cap
Market Cap £827.0m
Enterprise Value £519.3m
Revenue £2.51m
Position in Universe 2702nd / 6853

BUZZ-Atara Biotherapeutics: Up on promising data from cancer therapy across trials

Mon 15th March, 2021 10:32am
** Shares of drug developer  ATRA.O  up 9.2% at $18.45
pre-market; among top pct gainers across U.S. exchanges
    ** Co posts analysis from three trials testing its
treatment, tabelecleucel, for Epstein-Barr virus-driven
post-transplant lymphoproliferative disease*:nBwbFZf5Ga
    ** Says treatment helped patients live longer among those
with complete response and among patients with partial response
    ** "Data suggests that tab-cel may provide an effective
treatment option marked by long-term overall survival regardless
of partial or complete response" - ATRA
    ** Co on track to file for marketing application in U.S. for
the indication in Q3 of 2021 and for Europe in Q4
    ** Stock up 175% in last 12 months

 (Reporting by Trisha Roy in Bengaluru)
 ((; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.